home Home About Us Newsroom Real Talk: 12% of Americans report using GLP-1 medications In an episode of Real Talk, Denver7's Micah Smith discusses the many questions surrounding the immediate and long-term impacts of these type of drugs with patients, doctors and counselors Return to Newsroom Share on Facebook Share on LinkedIn Share on X November 17, 2025 More than 12% of Americans have used a GLP-1 medications for weight loss, according to a KFF (formerly Kaiser Family Foundation) poll involving about 1,500 respondents
Protocolo Combinado (Ipamorelina + CJC-1295) Dosis: 0,2 0,3 mg de Ipamorelina + 0,1 mg de CJC-1295 (= 46 clics) Duracin: 8 12 semanas Frecuencia: 1 2 al da Intervalo de ciclo: 4 semanas de descanso antes de repetir Objetivo / Descripcin: Combinacin sinrgica GHRH + GHRP estudiada por la amplificacin del pulso de GH y la respuesta de IGF-1
1 In response to glucose intake, the PPG neurons in the central nervous system (CNS) and the L-cells in the gut produce and secrete GLP-1, an inhibitory gastrointestinal hormone
When insulin requirements drop by 2030%, CGM data becomes even more critical
It often leads to needing a joint replacement
